Travere Therapeutics, Inc. (TVTX)
30.60
+0.38
(+1.26%)
USD |
NASDAQ |
Feb 12, 16:00
30.50
-0.10
(-0.33%)
After-Hours: 07:48
Travere Therapeutics Cash from Investing (Quarterly) : 86.59M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | -209.40M |
| Ligand Pharmaceuticals, Inc. | -353.44M |
| Plus Therapeutics, Inc. | 1.297M |
| BioStem Technologies, Inc. | -1.168M |
| Iovance Biotherapeutics, Inc. | 17.01M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 14.32M |
| Cash from Financing (Quarterly) | -65.34M |
| Free Cash Flow | -107.47M |
| Free Cash Flow Per Share (Quarterly) | -0.0085 |
| Free Cash Flow to Equity (Quarterly) | 68.95M |
| Free Cash Flow to Firm (Quarterly) | 1.879M |
| Free Cash Flow Yield | -3.87% |